Navigation Links
Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
Date:8/19/2007

PLYMOUTH MEETING, Pa., Aug. 1 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR) today reported that development partner MedImmune, Inc. has initiated a multi-dose, Phase 2a clinical trial with its monoclonal antibody (MAb) targeting interleukin-9 (IL-9) in adults with mild, persistent asthma. The placebo-controlled, dose-escalation study is designed to evaluate the safety and tolerability of multiple doses of the antibody. This trial is the second Phase 2a study currently underway with the MAb, known as MEDI-528. Genaera and MedImmune entered into a collaborative licensing agreement for this program in 2001.

"This study begins another important step in evaluating the potential of the anti-IL-9 antibody as a new, long-term maintenance or controller therapy for symptomatic, persistent asthma," said Jack Armstrong, President and Chief Executive Officer of Genaera. "We are pleased that the anti-IL-9 antibody is progressing through MedImmune's respiratory inflammation pipeline and remain excited to be part of this partnership. Furthermore, we are optimistic that this study will add to the body of clinical and preclinical data supporting development of MEDI-528 as a potential therapy for this very serious and unfortunately all too common disease."

Two previous Phase 1 single-dose, dose-escalation studies have been conducted to evaluate the safety, tolerability and pharmacokinetics of the anti-IL-9 MAb in healthy volunteers. The antibody was well tolerated in both studies. MedImmune is also conducting an ongoing Phase 2a study, initiated in late 2006, to evaluate the efficacy of a single intravenous dose of MEDI-528 and its effect on disease mechanisms in adults with atopic asthma. Plans to initiate a
'/>"/>

SOURCE Genaera Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 BiologicTx ® today announced ... 3-way Kidney Paired Donation transplant exchange utilizing BiologicTx,s proprietary ... July 9 at the Miami Transplant Institute, located at ... Kidney Paired Donation (KPD) is ... for kidney transplant with one another due to incompatible ...
(Date:7/22/2014)...  A central New York ... Total Artificial Heart implant is home, discharged from ... Freedom® portable driver to wait for a matching ... from a Syracuse architectural hardware company, suffered from ... medications, an implantable defibrillator and a pacemaker. ...
(Date:7/22/2014)... SAN DIEGO , July 22, 2014  Halozyme ... that it has resumed enrollment and dosing of patients ... PEGPH20 in patients with pancreatic cancer under the revised ... PEGPH20 is an investigational PEGylated form of Halozyme,s proprietary ... of tumors that accumulate hyaluronan. "Our ...
Breaking Medicine Technology:BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3
... April 12, 2011 HeartWare International, Inc. (NASDAQ: ... of less invasive, miniaturized circulatory support technologies that are ... that the HeartWare® Ventricular Assist System will be the ... and Lung Transplantation (ISHLT) 31st Annual Meeting and Scientific ...
... Reportlinker.com announces that a new market research report ... Nephrology and Urology Devices Market Outlook to 2017 ... and Urology Devices Market Outlook to 2017 ... Nephrology and Urology Devices Market Outlook to 2017" provides ...
Cached Medicine Technology:HeartWare Announces Presentations at The International Society of Heart and Lung Transplantation Annual Meeting 2HeartWare Announces Presentations at The International Society of Heart and Lung Transplantation Annual Meeting 3HeartWare Announces Presentations at The International Society of Heart and Lung Transplantation Annual Meeting 4Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 2Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 3Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 4Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 5Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 6Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 7Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 8Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 9Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 10Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 11Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 12Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 13Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 14Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 15
(Date:7/23/2014)... Townsend Security, a leading authority in ... i security solutions now support two factor authentication. This ... of relying on passwords as their only authentication mechanism. ... Alliance Two Factor Authentication software with the following ... Alliance AES/400 – High performance, NIST validated AES ...
(Date:7/23/2014)... St. Paul, MN (PRWEB) July 23, 2014 ... scheduled with paper, pencil and a spreadsheet. Now, the ... Online Employee Scheduling and Workforce Management system. , “Scheduling ... spreadsheet, was challenging. It was hard to keep track of ... only work from this time to this time, and we ...
(Date:7/23/2014)... five older Americans living with multiple chronic medical conditions, ... School of Public Health finds that the more ailments ... expectancy. The analysis, one of the first to examine ... among the elderly, may help explain why increases in ... report on the findings, based on an analysis of ...
(Date:7/22/2014)... July 22, 2014 Vitamin C is one ... creams mostly marketed to women in the United States. The ... for wrinkles list online for women to review at ... and oils is one way that beauty product manufacturers are ... approach, many companies are using mixtures of Vitamins C, E ...
(Date:7/22/2014)... Mountain View, California (PRWEB) July 23, 2014 ... to wearable devices . From now on, in ... the team offers software solutions for Google Glass as ... and connected devices. , A dynamic lifestyle requires ... official release, Google Glass has found application in healthcare, ...
Breaking Medicine News(10 mins):Health News:Townsend Security Brings Two Factor Authentication to Leading IBM i Security Solutions 2Health News:This Fire Department Allows Personnel to Schedule Themselves - Saving Administration Up To 60 Hours a Month 2Health News:This Fire Department Allows Personnel to Schedule Themselves - Saving Administration Up To 60 Hours a Month 3Health News:Life expectancy gains threatened as more older Americans suffer from multiple conditions 2Health News:Life expectancy gains threatened as more older Americans suffer from multiple conditions 3Health News:Best Vitamin C Serum for Wrinkles List Complied for Women at Consumer News Portal Online 2Health News:Provectus Announces Development for Google Glass and Wearables 2
... of Camembert cheese with the microorganism E.coli, products containing ... potential risk of food poisoning. The Food Standards Agency ... this cheese. ,A form of E.coli known ... has been believed to be responsible for the contamination. ...
... Nations Office on Drugs and Crimes (UNODC) fears that that ... in Pakistan and Afghanistan might turn to drugs to provide ... the agency has launched a series of workshops in collaboration ... Country Representative for UNODC said that the agency had increasingly ...
... Institutes of Health (NIH) has revealed that the use of ... in the US. There has however been an increase in ... University of Michigan conducted the 2005 Monitoring the Future (MTF) ... were good. , ,It found that cigarette smoking was ...
... Year resolutions to loose weight it has been found that ... is effective.// ,This has been suggested by the doctors ... fat diet is good for shedding the flab and getting ... of Medicine. It demonstrated that a diet based on low ...
... The Indian State of Uttar Pradesh’s Firozabad District appears to ... having taken preventive measures, several hundred children in the district ... and diarrhoea. ,With the spread of chicken ... worried. Even infants are rapidly falling victims to the disease. ...
... Seattle has revealed that chronic lower back pain can be ... from back pain were assessed by the study. The people ... progress when compared to those who participated in stretching and ... to be more useful than self-care books. After a 14-week ...
Cached Medicine News:Health News:Drug Use On The Decline Among US Youth 2Health News:Chicken pox Spreads Across Firozabad 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: